EXODERIL

This brand name is authorized in Austria, Estonia, Hong Kong, Lithuania, Poland, Romania, Turkey

Active ingredients

The drug EXODERIL contains one active pharmaceutical ingredient (API):

1 Naftifine
UNII 25UR9N9041 - NAFTIFINE HYDROCHLORIDE

Naftifine is a topical antifungal drug. it is used for the the treatment of interdigital tinea pedis caused by the organisms Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum.

Read about Naftifine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
D01AE22 Naftifine D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AE Other antifungals for topical use
Discover more medicines within D01AE22

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1020306, 1061075, 1061086, 1061110, 1722990
Country: HK Department of Health Drug Office Identifier(s): 53383
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1003009, 1003010, 1003011, 1074962, 1080372
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100087245
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W41598001, W41599001, W41599002
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699502650329, 8699516350680, 8699516510695

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.